NCT01585792View on ClinicalTrials.gov

Double Blind Comparative Study of TAK-875

PHASE3CompletedINTERVENTIONAL

Enrollment

80

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions

Diabetic Patients

Interventions

DRUG

TAK-875

DRUG

TAK-875

DRUG

Glimepiride

DRUG

Placebo

Trial Locations (2)

Unknown

Fukuoka

Sumida-ku

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Takeda

INDUSTRY